• M.D  National Defense Medical Center, Taiwan, R.O.C
• PhD    National Yang-Ming University, Taiwan, R.O.C

• Chief, Division of healthcare mangement, Healthcare and Service Center, Taipei Veterans General Hospital      
• Fellow of American College of Cardiology

• Professor, National Yang Ming Chiao Tung University

• Taipei Veterans General Hospital.
  2001-2002   Chief Resident, Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital.
  2002-2003   Chief Resident, Department of Medicine, Taipei Veterans General Hospital
  2003-2005   Fellow, Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital
  2005        Attending Physician, Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital
  2005        Attending Physician, Yuan-Shan Veterans Hospital, I-Lan
  2010-2011    Research Fellow, Diabetic Research Center, University of California, Irvine, United State
  2007-2014  Attending Physician, Healthcare Management Center and Division of Cardiology, Taipei Veterans General Hospital
  2014-present Director, Division of Health Management, Healthcare and Management Center, Taipei Veterans General Hospital

• License of physician, Taiwan

• Coronary artery disease
• Atherosclerosis
• Hypertension
• Healthcare management

• hbleu@vghtpe.gov.tw

1. Tsai TY, Hsu PF, Wu CH, Huang SS, Chan WL, Lin SJ, Chen JW, Lu TM, Leu HB. Association between Coronary Artery Plaque Progression and Liver Fibrosis Biomarkers in Population with Low Calcium Scores. Nutrients. 2022;14(15):3163.
2.  Tsai TY, Hsu PF, Wu CH, Yang YL, Chen SC, Huang SS, Chan WL, Lin SJ, Chen JW, Pan JP, Charng MJ, Chen YH, Wu TC, Lu TM, Huang PH, Cheng HM, Huang CC, Sung SH, Lin YJ, Leu HB. Association between phosphate and long-term outcome in CAD patients underwent coronary intervention. Sci Rep. 2021;11(1):20080.
3. Yang YL, Chen SC, Wu CH, Huang SS, Chan WL, Lin SJ, Chou CY, Chen JW, Ju-Pin P, Charng MJ, Chen YH, Wu TC, Lu TM, Hsu PF, Huang PH, Cheng HM, Huang CC, Sung SH, Lin YJ, Leu HB. Optimal blood pressure for patients with end-stage renal disease following coronary interventions. J Clin Hypertens (Greenwich). 2021; (8):1622-1630.
4. Hsu PF, Wang YW, Lin CC, Wang YJ, Ding YZ, Liou TL, Huang SS, Lu TM, Chan WL, Lin SJ, Leu HB. The association of the steatosis severity in fatty liver disease with coronary plaque pattern in general population. Liver Int. 2021;41(1):81-90.
5. Lim SS, Yang YL, Chen SC, Wu CH, Huang SS, Chan WL, Lin SJ, Chen JW, Chou CY, Pan JP, Charng MJ, Chen YH, Wu TC, Lu TM, Hsu PF, Huang PH, Cheng HM, Huang CC, Sung SH, Lin YJ, Leu HB. Association of variability in uric acid and future clinical outcomes of patient with coronary artery disease undergoing percutaneous coronary intervention. Atherosclerosis. 2020 ;297:40-46.

限於篇幅,以上謹為代表著作